364 related articles for article (PubMed ID: 35282446)
1. Gut and Vaginal Microbiomes in PCOS: Implications for Women's Health.
Gu Y; Zhou G; Zhou F; Li Y; Wu Q; He H; Zhang Y; Ma C; Ding J; Hua K
Front Endocrinol (Lausanne); 2022; 13():808508. PubMed ID: 35282446
[TBL] [Abstract][Full Text] [Related]
2. Gut and vaginal microbiomes on steroids: implications for women's health.
Graham ME; Herbert WG; Song SD; Raman HN; Zhu JE; Gonzalez PE; Walther-António MRS; Tetel MJ
Trends Endocrinol Metab; 2021 Aug; 32(8):554-565. PubMed ID: 34049772
[TBL] [Abstract][Full Text] [Related]
3. Female reproductive dysfunctions and the gut microbiota.
Chadchan SB; Singh V; Kommagani R
J Mol Endocrinol; 2022 Oct; 69(3):R81-R94. PubMed ID: 35900833
[TBL] [Abstract][Full Text] [Related]
4. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota.
Zhang M; Hu R; Huang Y; Zhou F; Li F; Liu Z; Geng Y; Dong H; Ma W; Song K; Song Y
Front Endocrinol (Lausanne); 2022; 13():933110. PubMed ID: 35928893
[TBL] [Abstract][Full Text] [Related]
5. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
6. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.
Mukherjee AG; Wanjari UR; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Dey A; Babu A; Renu K; Vellingiri B; Ramanathan G; Priya Doss C G; Elsherbiny N; Elsherbini AM; Alsamman AM; Zayed H; Gopalakrishnan AV
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677054
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.
Wang L; Zhou J; Gober HJ; Leung WT; Huang Z; Pan X; Li C; Zhang N; Wang L
Biomed Pharmacother; 2021 Jan; 133():110958. PubMed ID: 33171400
[TBL] [Abstract][Full Text] [Related]
8. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders.
Elkafas H; Walls M; Al-Hendy A; Ismail N
Front Cell Infect Microbiol; 2022; 12():1059825. PubMed ID: 36590579
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
10. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
11. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
12. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome.
Lu C; Wang H; Yang J; Zhang X; Chen Y; Feng R; Qian Y
Front Cell Infect Microbiol; 2021; 11():755741. PubMed ID: 34804995
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Gut Microbiota Alteration in the Patients and Animal Models with Polycystic Ovary Syndrome.
Zhou J; Qiu X; Chen X; Ma S; Chen Z; Wang R; Tian Y; Jiang Y; Fan L; Wang J
J Microbiol; 2023 Sep; 61(9):821-836. PubMed ID: 37824034
[TBL] [Abstract][Full Text] [Related]
14. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
15. Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.
Wang T; Sha L; Li Y; Zhu L; Wang Z; Li K; Lu H; Bao T; Guo L; Zhang X; Wang H
Front Endocrinol (Lausanne); 2020; 11():284. PubMed ID: 32670195
[TBL] [Abstract][Full Text] [Related]
16. Insights into New Therapeutic Approaches for the Treatment and Management of Polycystic Ovary Syndrome: An Updated Review.
Bashir R; Wani IA; Ganie MA
Curr Pharm Des; 2022; 28(18):1493-1500. PubMed ID: 35593345
[TBL] [Abstract][Full Text] [Related]
17. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
18. Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.
Zhou M; Yu J; Li X; Ruan Z; Yu S
J Cell Mol Med; 2024 Apr; 28(8):e18258. PubMed ID: 38546608
[TBL] [Abstract][Full Text] [Related]
19. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the power within: engineering the microbiome for enhanced gynecologic health.
Brennan C; Chan K; Kumar T; Maissy E; Brubaker L; Dothard MI; Gilbert JA; Gilbert KE; Lewis AL; Thackray VG; Zarrinpar A; Knight R
Reprod Fertil; 2024 Apr; 5(2):. PubMed ID: 38513356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
